Adjuvant carboplatin for treatment of splenic hemangiosarcoma in dogs: Retrospective evaluation of 18 cases (2011‐2016) and comparison with doxorubicin‐based chemotherapy

BACKGROUND: Doxorubicin‐based chemotherapy after splenectomy remains the standard of care for hemangiosarcoma in dogs, but prognosis is generally poor. HYPOTHESIS/OBJECTIVES: To determine clinical outcome with carboplatin chemotherapy after splenectomy compared to doxorubicin‐based protocols. A seco...

Descripción completa

Detalles Bibliográficos
Autores principales: Faulhaber, Erica A., Janik, Emily, Thamm, Douglas H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
SMALL ANIMAL
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295674/
https://www.ncbi.nlm.nih.gov/pubmed/34227148
http://dx.doi.org/10.1111/jvim.16212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295674/
https://www.ncbi.nlm.nih.gov/pubmed/34227148
http://dx.doi.org/10.1111/jvim.16212

Ejemplares similares